A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis

NCT03963401 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

219

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: PF-06700841
OTHER: Placebo

Sponsor

Pfizer